Skip to content

WHWK WHWK Return on equity

Return on equity at other companies

Eli Lilly logo
Eli LillyLLY
107.6%+29.9pp
Pfizer logo
PfizerPFE
10.6%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
14.5%-1.4pp
Gilead Sciences logo
Gilead SciencesGILD
43.2%+10.7pp
AbbVie logo
AbbVieABBV
89%+32.7pp
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-14.3%-5.0pp

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Calculated from WHWK’s reported figures.

Based on trailing twelve months.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's return on equity?
WHWK (WHWK) reported return on equity of -68.5% in Q1 2026.
How has WHWK's return on equity changed year-over-year?
WHWK's return on equity decreased by 487.5% year-over-year, from 17.7% to -68.5%.
What is the long-term trend for WHWK's return on equity?
Over 2 years (2023 to 2025), WHWK's return on equity has grown at a -33.9% compound annual growth rate (CAGR), from -49.9% to -21.8%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.